Shield Therapeutics Share Discussion Threads

[peachie 74] 26/3/2020 15:59

I could not believe it dropped below to start with !

[rafboy] 26/3/2020 15:59

Taken me ages to add just 1000 shares.

[qs99] 26/3/2020 15:43

hopefully see this back through a quid in short order!

[montyhedge] 26/3/2020 15:07

Strange those trades at 122p.

[montyhedge] 26/3/2020 15:06

Makes sense patients are weak, iron to build strength. ,

[peachie 74] 26/3/2020 14:56

Ordered another few. Interesting to what price I get !

87p. Bargain ;)

[peachie 74] 26/3/2020 14:46

I’m going to do some research into that Monty

[montyhedge] 26/3/2020 14:06

Of course not a doctor, but surely Coronavirus, to build strength back up must be iron.

[peachie 74] 26/3/2020 14:00

I would love to know.... In light of the current hospital bed crisis, just how far down the list IV iron infusions have dropped in terms of priority. Consultants must be looking at tablet alternatives surely. Beds and nursing staff being used to help the current poor patients affected by the virus. All routine surgery is cancelled until further notice.
Allocation of resources is so important atm

[peachie 74] 26/3/2020 13:55

Cheers Nobby

Agreed NY Boy. I had a lot much higher , but bought a fair few more in the 50s. Just would be nice to be back to normal levels ie 160/170 before US news etc. Then 200-250 becomes a distinct possibility in the not too distant future

GLA.

[montyhedge] 26/3/2020 13:53

Funny three biggest trades gone through at 122p, probably for tax reasons.

[peachie 74] 26/3/2020 13:53

Up 13% on 45,000 volume. Crikey.

[nobbygnome] 26/3/2020 13:48

Probably out of date now but there are 3 MMs on 80p and 2 on 85.

[ny boy] 26/3/2020 13:46

peachie74 L2 unimportant , just buy and hold long term. Some bought around 40p and have doubled their return. Still we await US commercialization deal news before we really take off, stay focused, dyor, stay safe. GL

[peachie 74] 26/3/2020 12:33

Can anyone see level 2 atm ?

[peachie 74] 26/3/2020 11:43

THE SHARE IS ON THE MOVE ! Need a quick dog out of the traps to catch this :))

Can’t even buy 1000 online atm. This is ready for takeoff fingers crossed. GLAH

[ny boy] 26/3/2020 11:27

Happy to hold here, it’s a long term investment for me,s Taylor long - stay strong

I took a punt on (GDR) @ 24p, as a new COVID play, see what happens, dyor as usual

Stay safe out there

[peachie 74] 26/3/2020 11:12

This could be 3 figures pretty soon again IMHO.

TBF should never have got close to being double figures !

[peachie 74] 26/3/2020 10:47

TBF I’m in a lot here ( obviously !), but have just gone back in on blue chips. May not be the bottom , but they’re definitely way off the top.
I’ll take a look at SNG. Cheers

[kop202] 26/3/2020 10:43

Peachie your obviously well up on these mattersSurprised you haven't joined Nobby on the SNG thread. Not tempted?

[peachie 74] 26/3/2020 10:24

Agreed Monty. This is creeping back on minuscule volume. If it sets off, it should fly.

[montyhedge] 26/3/2020 10:18

Just need that something to lite the blue touch paper for takeoff in the shareprice.

[peachie 74] 26/3/2020 09:48

The concluding lines to link above EE Northern Advisory group

Points to consider
 There has been no new published data to support the license extension of ferric maltol.
 Ferric maltol is not included in current BSG iron deficiency anaemia guidelines but these shall be updated in 2019.
 The initial cost of prescribing ferric maltol is significant in comparison to other oral iron preparations. However there are potential cost savings by fewer referrals to secondary care, a reduction in IV iron and associated costs including nursing time.
 The majority of cost savings would come from a reduction in the use of IV iron. IV iron is currently funded by secondary care. Primary care would absorb the responsibility and cost of prescribing ferric maltol.
 The reduction in IV iron use would increase capacity of day units in secondary Care

[peachie 74] 26/3/2020 09:40

Carl states in his presentation a couple of weeks ago how the Notthern treatment advisory group had taken on advising Feraccru